Reshaping the Depressed Brain: A Focus on Synaptic Health

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Smith K.A.
        • Fairburn C.G.
        • Cowen P.J.
        Relapse of depression after rapid depletion of tryptophan.
        Lancet. 1995; 349: P915-P919
        • Trivedi M.H.
        • Rush A.J.
        • Wisniewski S.R.
        • Nierenberg A.A.
        • Warden D.
        • Ritz L.
        • et al.
        Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice.
        Am J Psychiatry. 2006; 163: 28-40
        • Gerhard D.M.
        • Wohleb E.S.
        • Duman R.S.
        Emerging treatment mechanisms for depression: Focus on glutamate and synaptic plasticity.
        Drug Discov Today. 2016; 21: 454-464
        • Arnsten A.F.
        Stress weakens prefrontal networks: Molecular insults to higher cognition.
        Nat Neurosci. 2015; 18: 1376-1385
        • Holtzheimer P.E.
        • Husain M.M.
        • Lisanby S.H.
        • Taylor S.F.
        • Whitworth L.A.
        • McClintock S.
        • et al.
        Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multisite, randomised, sham-controlled trial.
        Lancet Psychiatry. 2017; 4: P839-P849
        • Yesavega J.A.
        • Fairchild J.K.
        • Mi Z.
        • Biswas K.
        • Davis-Karim A.
        • Phibbs C.S.
        • et al.
        Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: A randomized clinical trial.
        JAMA Psychiatry. 2018; 75: 884-893
        • Holtmaat A.
        • Svoboda K.
        Experience-dependent structural synaptic plasticity in the mammalian brain.
        Nat Rev Neurosci. 2009; 10: 647-658
        • Dincheva I.
        • Lynch N.B.
        • Lee F.S.
        The role of BDNF in the development of fear learning.
        Depress Anxiety. 2016; 33: 907-916
        • Li N.
        • Liu R.J.
        • Dwyer J.M.
        • Banasr M.
        • Lee B.
        • Son H.
        • et al.
        Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
        Biol Psychiatry. 2011; 69: 754-761
        • Mastrodonato A.
        • Martinez R.
        • Pavlova I.P.
        • LaGamma C.T.
        • Brachman R.A.
        • Robison A.J.
        • Denny C.A.
        Ventral CA3 activation mediates prophylactic ketamine efficacy against stress-induced depressive-like behavior.
        Biol Psychiatry. 2018; 84: 846-856

      Linked Article